Fight the New Drug Inc

Income Statement
Fiscal Year: 2024
Revenues in 2024
$841,023
Contributions
92%
Program Services
5%
Other
3%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Investments
0%
Expenses in 2024
$1,166,542
Salaries & Benefits
75%
Advertising & Promotion
9%
Offices, Occupancy & IT
8%
Fees to Service Providers
5%
Other
2%
Depreciation
<1%
Interest
<1%
Grants
0%
Benefits to Members
0%
Revenues
2023
2024
Change
Contributions
$552,079
$775,528
+40%
Government Grants
$29,066
$0
-100%
Fundraising Events
$0
$0
-
Program Services
$51,614
$42,621
-17%
Membership Dues
$0
$0
-
Investments
$0
$0
-
Other
$65,077
$22,874
-65%
Total Revenues
$697,836
$841,023
+21%
Expenses
2023
2024
Change
Grants
$0
$0
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$866,959
$871,970
+1%
Fees to Service Providers
$118,739
$58,722
-51%
Advertising & Promotion
$149,428
$110,572
-26%
Offices, Occupancy & IT
$63,923
$92,902
+45%
Interest
$2,470
$1,271
-49%
Depreciation
$12,427
$9,683
-22%
Other
$13,181
$21,422
+63%
Total Expenses
$1,227,127
$1,166,542
-5%
Net income
2023
2024
Change
Net income
-$529,291
-$325,519
+38%
Functional Expenses
Summary
2023
2024
Change
Program
$1,136,755
$1,092,402
-4%
Admin
$40,637
$56,249
+38%
Fundraising
$49,735
$17,891
-64%
Total Expenses
$1,227,127
$1,166,542
-5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)